Drl

Rediff.com » News » Drl

News for Drl

News
Business

'14+ Anti-Obesity Drugs In The Pipeline'

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent. IMAGE: Pens for the diabetes drug......

Sputnik V vaccine may be added to India's Covid armoury soon

‘We expect to get the approval in the next few weeks,’ says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL). IMAGE: Medics administer the first......

Expert panel seeks more data on Sputnik V Covid vaccine

‘No approval was given to Sputnik V on Thursday. Some queries have been asked on safety, efficacy, and logistics, which the firm will have answers to at the next meeting’ IMAGE:......

Sputnik V vaccine to be available in India from next week: Govt

India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi. Photograph: Kind courtesy Russian Direct Investment Fund on Facebook Sputnik V, the......

Covid vaccine could cost up to Rs 1000 in private market

While the Indian government has been procuring Covid-19 vaccines at low prices so far, manufacturers have to declare the prices of vaccines they would supply to the open market (industries, private......

USFDA's new draft biosimilar rules to benefit Indian biotech cos

The US Food and Drug Administration’s (USFDA)’s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars — lower-priced, near-replicas of complex biologic......

Indian Pharma Majors Ready With Weight Loss Drugs

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly. Kindly note the image has been posted only for representational purposes.......

VinFast disrupts EV market with most affordable midsize SUV

VinFast's VF6 storms into India as the most affordable electric SUV above 4 metres, packing premium features, 468km range, and free charging till 2028 to disrupt the EV market, observes Somnath......

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy’s Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company’s Q3 performance and......

Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition

Dr Reddy’s Laboratories (DRL) is set to acquire Haleon’s global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US.......

Drl

News for Drl

'14+ Anti-Obesity Drugs In The Pipeline'

Sputnik V vaccine may be added to India's Covid armoury soon

Expert panel seeks more data on Sputnik V Covid vaccine

Sputnik V vaccine to be available in India from next week: Govt

Covid vaccine could cost up to Rs 1000 in private market

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Indian Pharma Majors Ready With Weight Loss Drugs

VinFast disrupts EV market with most affordable midsize SUV

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS